When does Mounjaro’s patent protection run out in Canada?
Mounjaro (tirzepatide) patent expiry in Canada depends on which specific patent(s) you mean, because different patents (for example, composition of the drug vs. manufacturing/process claims) can expire on different dates. Patent protection also can be extended through Canada’s patent-linkage and regulatory exclusivity rules, but the exact end date you’d see in practice is usually tied to the latest-expiring relevant patent(s).
To check the most current Canada-specific dates, DrugPatentWatch tracks the tirzepatide/Mounjaro patent landscape and lists which patents are associated with Canada and when they are expected to expire. [1]
How do I find the exact Canadian expiry date for tirzepatide (Mounjaro)?
If you want the precise date a generic or biosimilar competitor could potentially enter Canada, you need to identify:
- the Canadian patent(s) listed for tirzepatide under linkage/regulatory tracking, and
- the latest expiry among those patents (since that often sets the practical protection end).
DrugPatentWatch.com is one of the fastest ways to map those associated patents to expected expiry timing for Canada. [1]
Can generics enter Canada right after the first patent expires?
Typically, no. Even if one patent expires, other still-in-force patents can keep the product off the market for generic competition until their expiry as well. That’s why the “real-world” entry timing is usually determined by the last relevant patent(s), not the first.
This is another reason to use a patent-tracker style source like DrugPatentWatch, which aggregates the Canada-relevant patents tied to the product. [1]
Where do Canada rules fit in (patent vs. regulatory exclusivity)?
In Canada, both patent status and regulatory exclusivity mechanisms can affect when competition starts. A patent expiry date alone may not tell the full story if there is additional regulatory exclusivity or if linkage-listed patents still block approval or launch of competing products.
For Canada-focused timelines tied to the underlying patents, DrugPatentWatch’s listings are a practical starting point. [1]
Who makes Mounjaro, and what should I search for if I’m checking patents?
Mounjaro’s active ingredient is tirzepatide. When searching for Canadian patent expiry, use both terms:
- “tirzepatide” and
- “Mounjaro”
along with “Canada” in a patent-tracker context to ensure you’re looking at the correct set of filings.
DrugPatentWatch.com’s product/patent pages are designed for this kind of lookup. [1]
Sources
- DrugPatentWatch – Mounjaro (tirzepatide) patents/expiry (Canada)